Next-Generation Probiotics As Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives

Overview

Journal Microorganisms

Specialty Microbiology

Date 2024 Mar 28

PMID 38543481

Authors

Mohamed E Abouelela

Yosra A Helmy

Affiliations

Soon will be listed here.

Abstract

Next-generation probiotics (NGPs) represent an innovative group of beneficial bacteria that are currently undergoing research and development. NGPs are designed not only for conventional use as foods or dietary supplements but are also tailored for pharmaceutical applications. Research indicates that NGPs show therapeutic promise in addressing various chronic ailments. Offering multiple advantages over conventional probiotics, NGPs present opportunities for personalized probiotic therapies, involvement in synthetic biology and gene editing, participation in combination therapies, targeted delivery methods, and application in therapeutic settings. Our review discusses the potential therapeutic effect of the NGPs, covering diverse research trajectories for NGPs, including their identification, characterization, and targeted delivery. Furthermore, this review elucidates the influence of NGPs on critical aspects of human health, specifically, gut health, immune function, and broader health outcomes. Mechanistic insights encompass the production of bioactive compounds, competitive interactions with pathogenic bacteria, the modulation of immune cell activity, and the reinforcement of the gut barrier. What is noteworthy is that the current review points out the prevalent NGP strains and their diverse sources, providing a highlight for the comprehensive framework for understanding their potential applications and their future benefits in the domain of advanced therapeutics.

Citing Articles

The Modulatory Role of Bioactive Compounds in Functional Foods on Inflammation and Metabolic Pathways in Chronic Diseases.

Ma Z, Fu C, Lee Y Foods. 2025; 14(5).

PMID: 40077524 PMC: 11899172. DOI: 10.3390/foods14050821.

Revolutionizing Nanovaccines: A New Era of Immunization.

Saleh M, El-Moghazy A, Elgohary A, Saber W, Helmy Y Vaccines (Basel). 2025; 13(2).

PMID: 40006673 PMC: 11860605. DOI: 10.3390/vaccines13020126.

Antimicrobial Activity of Probiotic Bacteria Isolated from Plants: A Review.

Sharma A, Lee H Foods. 2025; 14(3).

PMID: 39942088 PMC: 11817414. DOI: 10.3390/foods14030495.

Therapeutic Potential of subsp. B8762 on Gut and Respiratory Health in Infant.

Richmond R, Mageswary U, Ali A, Taib F, Koo T, Yusof A Int J Mol Sci. 2025; 26(3).

PMID: 39941091 PMC: 11818524. DOI: 10.3390/ijms26031323.

A Simplified Method for the Isolation of Extracellular Vesicles from Probiotic Bacteria and Their Characterization.

Sawant H, Bihl J, Borthakur A Int J Mol Sci. 2025; 26(3).

PMID: 39940832 PMC: 11817318. DOI: 10.3390/ijms26031058.

References

Cheng H, Yen G, Huang S, Chen S, Hsu C . The next generation beneficial actions of novel probiotics as potential therapeutic targets and prediction tool for metabolic diseases. J Food Drug Anal. 2022; 30(1):1-10. PMC: 9931004. DOI: 10.38212/2224-6614.3396. View

Helmy Y, Kassem I, Kumar A, Rajashekara G . Evaluation of the Impact of the Probiotic Nissle 1917 on 's Invasion and Intracellular Survival in Human Colonic Cells. Front Microbiol. 2017; 8:1588. PMC: 5572226. DOI: 10.3389/fmicb.2017.01588. View

Agostini S, Goubern M, Tondereau V, Salvador-Cartier C, Bezirard V, Leveque M . A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol Motil. 2012; 24(4):376-e172. DOI: 10.1111/j.1365-2982.2011.01865.x. View

Ducrotte P, Sawant P, Jayanthi V . Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol. 2012; 18(30):4012-8. PMC: 3419998. DOI: 10.3748/wjg.v18.i30.4012. View

Yoon W, Yoo Y, Chae Y, Kee S, Kim B . Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment. Ann Oncol. 2018; 29(9):2010-2017. DOI: 10.1093/annonc/mdy240. View

Guglielmetti S, Mora D, Gschwender M, Popp K . Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011; 33(10):1123-32. DOI: 10.1111/j.1365-2036.2011.04633.x. View

Steidler L . Genetically engineered probiotics. Best Pract Res Clin Gastroenterol. 2003; 17(5):861-76. DOI: 10.1016/s1521-6918(03)00072-6. View

Gao T, Wang X, Li Y, Ren F . The Role of Probiotics in Skin Health and Related Gut-Skin Axis: A Review. Nutrients. 2023; 15(14). PMC: 10385652. DOI: 10.3390/nu15143123. View

Kalenik A, Kardas K, Rahnama A, Sirojc K, Wolanczyk T . Gut microbiota and probiotic therapy in ADHD: A review of current knowledge. Prog Neuropsychopharmacol Biol Psychiatry. 2021; 110:110277. DOI: 10.1016/j.pnpbp.2021.110277. View

10.

Sanchez M, Darimont C, Drapeau V, Emady-Azar S, Lepage M, Rezzonico E . Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr. 2013; 111(8):1507-19. DOI: 10.1017/S0007114513003875. View

11.

Maleki-Kakelar H, Dehghani J, Barzegari A, Barar J, Shirmohamadi M, Sadeghi J . induces apoptosis in gastric cancer cells via modulation of signaling pathways in . Bioimpacts. 2020; 10(2):65-72. PMC: 7186545. DOI: 10.34172/bi.2020.09. View

12.

Gautier T, David-Le Gall S, Sweidan A, Tamanai-Shacoori Z, Jolivet-Gougeon A, Loreal O . Next-Generation Probiotics and Their Metabolites in COVID-19. Microorganisms. 2021; 9(5). PMC: 8146258. DOI: 10.3390/microorganisms9050941. View

13.

Zhang Y, Zhang Y, Xia L, Zhang X, Ding X, Yan F . Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein. Appl Environ Microbiol. 2012; 78(21):7603-10. PMC: 3485711. DOI: 10.1128/AEM.01390-12. View

14.

Petrova M, Imholz N, Verhoeven T, Balzarini J, Van Damme E, Schols D . Lectin-Like Molecules of Lactobacillus rhamnosus GG Inhibit Pathogenic Escherichia coli and Salmonella Biofilm Formation. PLoS One. 2016; 11(8):e0161337. PMC: 4990349. DOI: 10.1371/journal.pone.0161337. View

15.

Fontana L, Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S, Gil A . Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr. 2013; 109 Suppl 2:S35-50. DOI: 10.1017/S0007114512004011. View

16.

Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M . Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota. Nat Commun. 2022; 13(1):4477. PMC: 9388534. DOI: 10.1038/s41467-022-32015-7. View

17.

Bernstein C, Fried M, Krabshuis J, Cohen H, Eliakim R, Fedail S . World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. 2009; 16(1):112-24. DOI: 10.1002/ibd.21048. View

18.

Jiang T, Li Y, Li L, Liang T, Du M, Yang L . 070103 Fermented Milk Improve Glucose and Lipid Metabolism Disorders by Regulating Gut Microbiota in Mice. Nutrients. 2022; 14(19). PMC: 9573661. DOI: 10.3390/nu14194050. View

19.

Ji P, An B, Jie Z, Wang L, Qiu S, Ge C . Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy. Mater Today Bio. 2022; 18:100515. PMC: 9792908. DOI: 10.1016/j.mtbio.2022.100515. View

20.

Bermudez-Humaran L, Langella P . Use of Traditional and Genetically Modified Probiotics in Human Health: What Does the Future Hold?. Microbiol Spectr. 2017; 5(5). PMC: 11687540. DOI: 10.1128/microbiolspec.BAD-0016-2016. View